Showing results (81-90 of 278) with videos related to
Sort By:
Pageof 28
Science Advances|May 4, 2022
Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domainMatthew D Gray, Junli Feng, Connor E Weidle, et al.Journal of Virology|December 6, 2015
A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A AntibodiesShilei Ding, Maxime Veillette, Mathieu Coutu, et al.Plos Pathogens|February 25, 2020
Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodiesThach H Chu, Andrew R Crowley, Iara Backes, et al.Human Immunology|June 29, 2004
HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected EthiopiansGuido Ferrari, Jeffrey R Currier, Matthew E Harris, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2012
Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infectionCatherine Riou, Vitaly V Ganusov, Suzanne Campion, et al.AIDS Research and Human Retroviruses|July 31, 2012
Acute HIV-1 infection in the Southeastern United States: a cohort studyMehri S McKellar, Anna B Cope, Cynthia L Gay, et al.Mbio|July 2, 2020
Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine TrialWilliam D Tolbert, Verna Van, Rebekah Sherburn, et al.Frontiers in Immunology|December 13, 2019
Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector CellsLeigh Fisher, Melissa Zinter, Sherry Stanfield-Oakley, et al.Plos One|April 16, 2015
Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adultsAgricola Joachim, Charlotta Nilsson, Said Aboud, et al.Retrovirology|October 31, 2021
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody featuresHao D Cheng, Karen G Dowell, Chris Bailey-Kellogg, et al.Pageof 28